Powder & Bulk Solids is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Swiss CDMO Invests in Powder Containment, Extends Spray Drying Capabilities

Image courtesy of Micro-Sphere Spray_Dryer_MICRO_SPHERE.jpg
Micro-Sphere PSD2 spray dryer
Micro-Sphere has added new spray drying technology and increased high containment capabilities.

Micro-Sphere has added to its contract development and manufacturing expertise with new spray drying technology and increased high containment capabilities.

The Swiss contract development and manufacturing organization (CDMO), which specializes in spray drying and capsule filling, has invested more than €3.5 million bringing on-line a new PSD2 spray dryer and associated technical area and clean room at its state-of-the-art facility in Monteggio.

The new equipment expands the CDMO’s spray drying capabilities in both clinical and commercial manufacturing.

“Customer demand for GMP spray drying is increasing because of the need to support poorly soluble drugs,” said Micro-Sphere CEO Michael Grassberger. “This is not our first spray dryer project and we have used our experience, plus GEA’s professional support, to accelerate this project and meet customer demand despite the restraints brought by COVID-19.”

Image courtesy of Micro-Sphere Powder_Glove_MICRO_SPHERE.jpg

Micro-Sphere powder glove box isolator

In addition to the PSD2 spray dryer, the company has also invested in its high containment capabilities, (specifically dispensing) with the purchase of a rigid glove box isolator that allows handling of HAPI with an OEL (occupational exposure limit) down to 30 ng/cu m.

“There has been a significant rise in demand for high potent compounds to be spray dried, with an increasing incidence of generic HPAPI, which confirmed our decision to invest in our high containment capabilities,” Grassberger added. This investment diversifies Micro-Sphere’s capability to address these demands and broadens our manufacturing services, meaning we can spray dry high potent compounds on a big scale, whilst also boosting our high containment expertise.

“Greater awareness and concern for safety in the industry are all factors that have led to a need for a well-defined multiple response to containment issues. Micro-Sphere wants to become and be recognized as a key-partner to this industry.”

The new equipment is part of the CDMO’s continued investment into expanding its GMP manufacturing capabilities and comes in response to increased demand for spray drying and inhalables from companies ranging from big pharma to small virtual firms.

From its EU-GMP-, FDA-, and SwissMedic-approved facility in Monteggio, Ticino, Micro-Sphere’s expert team supports customers in the US, Europe, New Zealand, and Asia with spray drying capabilities for the development and manufacture of both potent and non-potent pharmaceutical products, with a particular focus on inhalable dosage forms.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish